| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | PCVX | Common Stock | 36,083 | 17 Apr 2025 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | PCVX | Stock Option (right to buy) | 17 Apr 2025 | Common Stock | 96,010 | $25.06 | Direct | F2 | ||||||
| holding | PCVX | Stock Option (right to buy) | 17 Apr 2025 | Common Stock | 45,000 | $24.79 | Direct | F3 | ||||||
| holding | PCVX | Stock Option (right to buy) | 17 Apr 2025 | Common Stock | 15,000 | $47.95 | Direct | F4 | ||||||
| holding | PCVX | Stock Option (right to buy) | 17 Apr 2025 | Common Stock | 62,143 | $41.67 | Direct | F5 | ||||||
| holding | PCVX | Stock Option (right to buy) | 17 Apr 2025 | Common Stock | 30,000 | $73.82 | Direct | F6 | ||||||
| holding | PCVX | Performance Stock Option (right to buy) | 17 Apr 2025 | Common Stock | 28,907 | $102.70 | Direct | F7 | ||||||
| holding | PCVX | Performance Restricted Stock Units | 17 Apr 2025 | Common Stock | 11,783 | $0.000000 | Direct | F8 | ||||||
| holding | PCVX | Stock Option (right to buy) | 17 Apr 2025 | Common Stock | 44,903 | $74.22 | Direct | F9 |
| Id | Content |
|---|---|
| F1 | This amount includes 23,584 restricted stock units ("RSUs") that, upon vesting, will be settled in shares of the Issuer's Common Stock on a 1-for-1 basis. The RSUs were granted in four tranches: On March 2, 2022; March 1, 2023; February 29, 2024; and February 27, 2025. The RSUs vest(ed) as to 25% of the shares subject to the award at the first sixth-months following grant, and 12.5% of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer through each such date. |
| F2 | 1/4 of shares subject to the option vested on October 1, 2022, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date. |
| F3 | 1/48 of shares subject to the option vested on April 2, 2022, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date. |
| F4 | 1/48 of shares subject to the option vested on January 30, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date. |
| F5 | 1/48 of shares subject to the option vested on April 1, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date. |
| F6 | 1/48 of shares subject to the option vested on March 31, 2024, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date. |
| F7 | As part of a company-wide grant to all eligible employees of the Issuer, on November 7, 2024 (the "Grant Date"), the Reporting Person was granted a performance stock option to purchase 28,907 shares of the Issuer's Common Stock at a per share exercise price of $102.70. The option is subject to (1) a service-based vesting condition (vesting as to one-third of the shares on each of the third, fourth and fifth anniversaries of the Grant Date) and (2) a performance-vesting condition (which generally requires that the trading price of the Issuer's Common Stock average, over a one-year period, is at least $154.05 (150% of the Grant Date closing price)). |
| F8 | Represents the target number of shares of Issuer's Common Stock underlying an award of performance restricted stock units ("PSUs"). Each PSU represents the contingent right to receive one share of the Issuer's Common Stock. The attainment of the performance vesting condition will be based on the Issuer's percentile rank within a peer group based on total shareholder return ("TSR") during a four-year performance period that commenced on November 7, 2024, the Grant Date, subject to the Reporting Person's continuous service with the Issuer through completion of the performance period. The actual number of shares of the Issuer's Common Stock deliverable with respect to the award varies based on performance and ranges from 0% to 250% of the target number of shares. |
| F9 | 1/48 of shares subject to the option vested on March 27, 2025, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date. |